Cited by 224Alzheimer's disease research and treatmentsDementia and Cognitive Impairment ResearchNeuroinflammation and Neurodegeneration Mechanisms

Binding of F-spondin to amyloid-β precursor protein: a candidate amyloid-β precursor protein ligand that modulates amyloid-β precursor protein cleavage

Open access
Ho, Angela, Südhof, Thomas C.·2004·Proceedings of the National Academy of Sciences

Abstract

Amyloid-β precursor protein (APP), a type I membrane protein, is physiologically processed by α- or β-secretases that cleave APP N-terminal to the transmembrane region. Extracellular α-/β-cleavage of APP generates a large secreted N-terminal fragment, and a smaller cellular C-terminal fragment. Subsequent γ-secretase cleavage in the transmembrane region of the C-terminal fragment induces secretion of small extracellular peptides, including Aβ 40 and Aβ 42 , which are instrumental in the pathogenesis of Alzheimer's disease, and intracellular release of a cytoplasmic tail fragment. Although APP resembles a cell-surface receptor, no functionally active extracellular ligand for APP that might regulate its proteolytic processing has been described. We now show that F-spondin, a secreted signaling molecule implicated in neuronal development and repair, binds to the conserved central extracellular domain of APP and inhibits β-secretase cleavage of APP. Our data indicate that F-spondin may be an endogenous regulator of APP cleavage, and suggest that the extracellular domains of APP are potential drug targets for interfering with β-secretase cleavage.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1073/pnas.0308655100

Cites

43 of 43 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • F-spondin may function as a linker between ApoER2 and APP through its interaction with extracellular and intracellular domains of APP.

    “F-spondin may function as a linker between ApoER2 and APP through its interaction with extracellular and intracellular domains of APP (Ho and Sudhof, 2004).”

    From The role of apolipoprotein E in Alzheimer's disease (2009) · cites this paper as Ho and Sudhof, 2004

    The Results (page unavailable) show that F-spondin binds the extracellular central domain of APP. The Discussion (page unavailable) identifies APP and APLPs as its binding partners, but does not describe an ApoER2–APP link or binding to an intracellular APP domain. (LLM, conf=0.88)

    Experimental — accuracy not yet measured
  • F-spondin binds both ApoER2 and APP, enhances their surface expression, and reduces Aβ formation.

    “The extracellular ligand, F-spondin, binds both ApoER2 and APP, enhances their surface expression, and reduces A␤ formation (65,66).”
  • ApoER2 binds thrombospondin repeats 1-4 of F-spondin, whereas APP binds the Reelin and Spondin domain of F-spondin.

    “ApoER2 binds the thrombospondin repeats 1-4 (pink triangles) of F-spondin, whereas APP binds the Reelin and Spondin domain of F-spondin (65, 66).”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 4

  1. [17]Sprecher, C. A., Morgenstern, K. A., Mathewes, S., Dahlen, J. R., Schrader, S. K., Foster, D. C. & Kisiel, W. (1993) Biochemistry 32**,** 4481-4486.8485127 [[Google Scholar](https://scholar.google.com/scholar_lookup?journal=Biochemistry&volume=32&publication_year=1993&pages=4481&)]
  2. [18]Slunt, H. H., Thinakaran, G., Von Koch, C., Lo, A. C., Tanzi, R. E. & Sisodia, S. S. (1994) J. Biol. Chem. 269**,** 2637-2644. [[PubMed](https://pubmed.ncbi.nlm.nih.gov/8300594/)] [[Google Scholar](https://scholar.google.com/scholar_lookup?journal=J.%20Biol.%20Chem.&volume=269&publication_year=1994&pages=2637&pmid=8300594&)]
  3. [22]Li, Q. & Südhof, T. C. J. Biol. Chem., in press.
  4. [34]Ushkaryov, Y. A., Hata, Y., Ichtchenko, K., Moomaw, C., Afendis, S., Slaughter, C. A. & Südhof, T. C. (1994) J. Biol. Chem. 269**,** 11987-11992. [[PubMed](https://pubmed.ncbi.nlm.nih.gov/8163501/)] [[Google Scholar](https://scholar.google.com/scholar_lookup?journal=J.%20Biol.%20Chem.&volume=269&publication_year=1994&pages=11987&pmid=8163501&)]

Cited by

Sorted by citations

Authors
Ho, A., & Südhof, T. C.
Affiliations
Howard Hughes Medical Institute (US)
Venue
Proceedings of the National Academy of Sciences
Published
2004-02-17
Volume
101
Issue
8
Pages
2548-2553
ISSN
  • 0027-8424 (ISSN-L)
  • 1091-6490
OpenAlex
W1971856927
Cited by
224
References
43
Citations by year
2026: 5 · 2025: 5 · 2024: 6 · 2023: 5 · 2022: 3 · 2021: 7 · 2020: 6 · 2019: 4 · 2018: 10 · 2017: 10 · 2016: 17 · 2015: 11 · 2014: 8 · 2013: 15 · 2012: 11
FWCI
8.63
Type
journal article
Language
en
Open access
Locations
  • Proceedings of the National Academy of Sciences (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institute on Aging (F32AG005844, AG05844)
  • National Institute of Mental Health (R01MH069585, R01-MH59686-01)
Topics
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Keywords
F-spondin, amyloid precursor protein, APP cleavage, beta-secretase inhibition, amyloid-beta, Alzheimer's disease, gamma-secretase, therapeutic target
MeSH terms
Animals, Brain, Cell Line, Chromatography, Affinity, Humans, Hydrolysis, Kinetics, Ligands, Peptides, Recombinant Fusion Proteins, Transfection, Extracellular Matrix Proteins, Amyloid beta-Protein Precursor, Intercellular Signaling Peptides and Proteins, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review